Douglas F. Kling

Insider Reports History

Entity
Individual
Location
C/O Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster, NJ
Signature
/s/ Louise Kooij by Power of Attorney from Douglas F. Kling
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas F. Kling:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NewAmsterdam Pharma Co N.V. Chief Operating Officer Option (right to buy) 324K Jan 1, 2024 Direct

Insider Reports Filed by Douglas F. Kling

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NAMS NewAmsterdam Pharma Co N.V. Jan 1, 2024 1 $0 4 Jan 3, 2024 Chief Operating Officer
NAMS NewAmsterdam Pharma Co N.V. Dec 29, 2023 0 $0 3 Dec 29, 2023 Chief Operating Officer